via The Scientist RSS https://ift.tt/1ylOcuv The group’s 7-2 ruling in favor of the therapeutic represents a shift from previous deliberations, in which data on its effectiveness was deemed insufficient. https://ift.tt/d7IVlYJ September 15, 2022 at 12:48AM